To assess the efficacy of oral ginger powder for prevention of postoperative bowel ileus in benign gynecologic abdominal hysterectomy. ginger, benign gynecologic surgery, postoperative bowel ileus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients included those diagnosed with benign gynecological conditions and scheduled for abdominal hysterectomy with or without adnexal surgery
Exclusion criteria
Exclusion criteria: had (a) a history of carminative drug use, (b) allergy to ginger, (c) reoperation within 24 hours, (d) immobility such as being on a ventilator, unconsciousness, or in shock, (e) intraoperative complications involving the gastrointestinal organs, kidneys, ureters or urinary bladder system, (f) underlying gastrointestinal disease such as gastroesophageal reflux disease and dyspepsia, (g) underlying chronic kidney disease (GFR < 30 ml/min/1.73m2), (h) use of anticoagulants such as warfarin, (i) postoperative flatus before the start of the intervention, (j) underlying respiratory disease such as COPD, asthma, or lung cancer, (k) peripheral arterial occlusion disease, (l) an operative time > 3 hours, (m) a low albumin level (< 3.5 g/dL), or (n) intraabdominal infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to first flatus until discharge mean | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first defecation until discharge mean,Time to first defecation Time to first defecation mean,postoperative vomiting post operative day1-3 number,Adverse events until discharge number,Additional antiflatulent or laxative drug requirements until discharge number | — |
Countries
Thailand
Contacts
khonkaen hospital